The predictive value of serum intercellular adhesion molecule 1 for the progression of diabetic kidney disease in type 2 diabetic patients

Open access


In type 2 diabetes, the progressive nature of diabetic kidney disease (DKD) induces high risk of morbidity and mortality. The aim of our study was to assess the predictive value of serum intercellular adhesion molecule 1 (ICAM 1) for the increasing of albuminuria in early stages of type 2 DKD. Consecutive type 2 diabetic patients with a one year followed up were included in this study. Outcome measurement for assessing the progression of diabetic kidney disease was the change in urinary albumin to creatinine ratio (ΔuACR). 93 type 2 diabetic patients were enrolled in the study, of which 58 were normoalbuminuric and 35 patients were albuminuric. Their mean urinary albumin excretion was in microalbuminuric stage and had a close to normal estimated glomerular filtration rate. ΔuACR disclosed a positive correlation to baseline serum ICAM 1 (p=0.003, r= 0.31) and serum creatinine (p=0.026, r=0.23). In multiple regression, ICAM-1 (p=0.002) was the main determinant of ΔuACR. The correlation was even stronger in albuminuric patients (p=0.0003, r=0.57). In our type 2 diabetic patients, the main predictor of increase in uACR over one year of follow-up is baseline ICAM -1 level, with a particular role in albuminuric patients. It seems that ICAM-1 might be useful non-invasive biomarker in predicting the progression of DKD.

1. Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, De-Álvaro F, Navarro-González JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes. 2012 Jan 15;3(1):7-18

2. Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011 Jun;7(6):327-40

3. Rivero A, Mora C, Muros M, García J, Herrera H, Navarro-González JF. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond). 2009 Mar; 116(6):479-92

4. Wu CC, Sytwu HK, Lu KC, Lin YF. Role of T cells in type 2 diabetic nephropathy. Exp Diabetes Res. 2011; 2011:514738

5. Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, De-Álvaro F, Navarro-González JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes. 2012 Jan 15;3(1):7-18

6. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000; 11:828-30

7. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT; PREVEND Study Group. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol. 2008 Oct 15;168(8):897-905

8. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106(14):1777-82

9. Gu HF, Ma J, Gu KT, Brismar K., Kerstin Brismar. Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy. Front Endocrinol (Lausanne). 2012; 3: 179

10. Ikezumi Y, Hurst LA, Masaki T, Atkins RC, Nikolic- Paterson DJ. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial proliferation. Kidney Int 2003; 63(1): 83−95

11. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 2004; 19(12):2987-96

12. Matsui H, Suzuki M, Tsukuda R, Iida K, Miyasaka M, Ikeda H. Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty. Diabetes Res Clin Pract 1996; 32(1-2):1-9

13. Watanabe N, Shikata K, Shikata Y, Sarai K, Omori K, Kodera R, et al. Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy. Acta Med Okayama. 2011 Aug;65(4):247-57

14. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, et al. Intercellular adhesion molecule-1 deficient mice are resistant against renal injury after induction of diabetes.Diabetes, 2003; 52(10): 2586-93

15. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH. Intracellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol, 2005; 16(6): 1711-22

16. Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O'Donnell CJ, et al. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant. 2011; 26(3): 920-6

17. Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, et al. Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial. Diabetes Care. 2008; 31(12): 2338-43

18. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, et al. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care. 2008; 31(6):1170-76

19. Lenghel AR, Kacso IM, Bondor CI, Rusu C, Rahaian R, Gherman Caprioara M. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract. 2012;95(1):55-61

20. Cha JJ, Hyun YY, Jee YH, Lee MJ, Han KH, Kang YS, et al. Plasma Concentration of Soluble Intercellular Adhesion Molecule-1 (sICAM-1) is Elevated in Type 2Diabetic Patients, and sICAM-1 Synthesis is Associated with Leptin-Induced Activation of the Mitogen-Activated Protein Kinase (MAPK) Pathway. Inflammation. 2013 Aug; 36(4): 878-87

21. Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk C, Tarnow L, et al. Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy. Diabetes. 2006 Dec;55(12):3550-5

22. Raluca Moldovan, Ina Kacsò, Mirela Gherman- Căprioară. Relationship between soluble intercellular adhesion molecule 1 and clinically manifest cardiovascular disease in diabetic chronic hemodialysis patients. Rev Romana Med Lab. 2012;20(4):353-361 406

Revista Romana de Medicina de Laborator

Romanian Journal of Laboratory Medicine

Journal Information

IMPACT FACTOR 2018: 0,800
5-year IMPACT FACTOR: 0,655

CiteScore 2017: 0.31

SCImago Journal Rank (SJR) 2018: 0.194
Source Normalized Impact per Paper (SNIP) 2018: 0.306

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 160 126 13
PDF Downloads 60 51 8